Research report

China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 - 2025: Clinical Chemistry, Immunoassay, Molecular Testing, SMBG, Point of Care Testing (POCT), Hematology, Coagulation, Microbiology, Genetic Testing, Infectious Diagnostics, Histology and Cytology

Format : Pdf

Publish Date: 02nd April 2018

Pages: 85

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 - 2025.

The market is driven by number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories. 

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 - 2025.

The market is driven by number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories. 

“China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 - 2025: Clinical Chemistry, Immunoassay, Molecular Testing, SMBG, Point of Care Testing (POCT), Hematology, Coagulation, Microbiology, Genetic Testing, Infectious Diagnostics, Histology and Cytology” presents an in-depth assessment of the in vitro diagnostics(IVD) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for in vitro diagnostics(IVD) in China. The research includes historic data from 2012 to 2017 and forecasts until 2025.

The report contains a granular analysis of the China in vitro diagnostics market segmentation by 11 applications and illustrative forecast to 2025. A comprehensive analysis has been done on market share of China in vitro diagnostics by application, end-user and company share by revenue. 

The report also includes assessment of in vitro diagnostics regulation in China. Key trends in terms of partnerships and recent developments are analyzed with details. The report also explores detailed description of growth drivers, restraints, trends and opportunities of the China in vitro diagnostics market.

Market Segmentation by Application and Analysis (2012 - 2025)

Clinical Chemistry
Immunoassay
Molecular Testing
Self–Monitoring of Blood Glucose (SMBG)
Point of Care Testing (POCT)
Hematology
Coagulation
Microbiology
Genetic Testing
Infectious Diagnostics
Histology and Cytology

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
 
Roche Diagnostics
Abbott Laboratories
Siemens Healthineers
Sysmex Corporation
Mindray Medical International Limited
Beckman Coulter Inc
Shanghai Fosun Pharmaceutical Group
Thermo Fisher Scientific Inc
Hologic Inc
Qiagen
Cepheid
Bio-Rad Laboratories Inc
Da An Gene Co. Ltd
Shanghai Kehua Bio–Engineering Co. Ltd.

The Latest Industry Data Included in this Report:

China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025)
China In Vitro Diagnostics Market Dynamics
China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025)
China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025)
China In Vitro Diagnostics Market, Company Share by Revenue, 2017
China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017
Assessment of In Vitro Diagnostics Regulation in China
Major Partnership Deals in China In Vitro Diagnostics Market
Recent Developments in China In Vitro Diagnostics Market
Overview of Key Companies in China In Vitro Diagnostics Market

1. Executive Summary

2. China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025) 

3. China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025) 

4. China In Vitro Diagnostics Market, Company Share by Revenue, 2017

5. China In Vitro Diagnostics Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Trends & Opportunities
 
6. China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025) 
 
6.1 Clinical Chemistry
6.2 Immunoassay
6.3 Molecular Testing
6.4 Self–Monitoring of Blood Glucose (SMBG) 
6.5 Point of Care Testing (POCT) 
6.6 Hematology
6.7 Coagulation
6.8 Microbiology
6.9 Genetic Testing
6.10 Infectious Diagnostics
6.11 Histology and Cytology
 
7. China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017
 
8. Assessment of In Vitro Diagnostics Regulation in China

9. Major Partnership Deals in China In Vitro Diagnostics Market

10. Recent Developments in China In Vitro Diagnostics Market
 
11. Overview of Key Companies in China In Vitro Diagnostics Market
 
11.1 Roche Diagnostics
11.1.1 Company Overview
11.2 Abbott Laboratories
11.2.1 Company Overview
11.3 Siemens Healthineers
11.3.1 Company Overview
11.4 Sysmex Corporation
11.4.1 Company Overview
11.5 Mindray Medical International Limited
11.5.1 Company Overview
11.6 Beckman Coulter Inc
11.6.1 Company Overview
11.7 Shanghai Fosun Pharmaceutical Group
11.7.1 Company Overview
11.8 Thermo Fisher Scientific Inc
11.8.1 Company Overview
11.9 Hologic Inc
11.9.1 Company Overview
11.10 Qiagen
11.10.1 Company Overview
11.11 Cepheid
11.11.1 Company Overview
11.12 Bio-Rad Laboratories Inc
11.12.1 Company Overview
11.13 Da An Gene Co. Ltd. 
11.13.1 Company Overview
11.14 Shanghai Kehua Bio–Engineering Co. Ltd. 
11.14.1 Company Overview

List of Tables:

Table 3–1: China In Vitro Diagnostics Market Revenue Share(Percent),2012 – 2017
Table 3–2: China In Vitro Diagnostics Market Revenue Share Forecast(Percent),2018 – 2025

List of Figures: 

Figure 2 1: China In Vitro Diagnostics Market Revenue (Million US$), 2012 – 2017
Figure 2 2: China In Vitro Diagnostics Market Revenue Forecast (Million US$), 2018 – 2025
Figure 4 1: China In Vitro Diagnostics Market, Company Share by Revenue (Percent), 2017
Figure 6 1: China Clinical Chemistry Market Revenue (Million US$), 2012 – 2017
Figure 6 2: China Clinical Chemistry Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 3: China Immunoassay Market Revenue (Million US$), 2012 – 2017
Figure 6 4: China Immunoassay Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 5: China Molecular Testing Market Revenue (Million US$), 2012 – 2017
Figure 6 6: China Molecular Testing Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 7: China SMBG Market Revenue (Million US$), 2012 – 2017
Figure 6 8: China SMBG Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 9: China POCT Market Revenue (Million US$), 2012 – 2017
Figure 6 10: China POCT Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 11: China Hematology Market Revenue (Million US$), 2012 – 2017
Figure 6 12: China Hematology Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 13: China Coagulation Market Revenue (Million US$), 2012 – 2017
Figure 6 14: China Coagulation Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 15: China Microbiology Market Revenue (Million US$), 2012 – 2017
Figure 6 16: China Microbiology Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 17: China Genetic Testing Market Revenue (Million US$), 2012 – 2017
Figure 6 18: China Genetic Testing Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 19: China Infectious Diagnostics Market Revenue (Million US$), 2012 – 2017
Figure 6 20: China Infectious Diagnostics Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 21: China Histology and Cytology Market Revenue (Million US$), 2012 – 2017
Figure 6 22: China Histology and Cytology Market Revenue Forecast (Million US$), 2018 – 2025
Figure 7 1: China In Vitro Diagnostics Market Share by End-User(Percent),2017